Contrôle de l’anxiété par les récepteurs de la sérotonine 5-HT2c de la strie terminale - Une explication des effets anxiogènes des inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) ?

Joël Bockaert; Carine Bécamel

doi:10.1051/medsci/20173301015

Home

All issues

Volume 33 / No 1 (Janvier 2017)

Med Sci (Paris), 33 1 (2017) 87-89

References

Free Access

Issue		Med Sci (Paris) Volume 33, Number 1, Janvier 2017 Matériaux pour la médecine de demain


Page(s)		87 - 89
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/20173301015
Published online		25 January 2017

Guimarães FS, Zangrossi H, Jr, Del Ben CM, Graeff FG, Müller CP, Jacobs BL. Serotonin in panic and anxiety disorders. Handbook of the behavioral neurobiology of serotonin. London : Academic Press, 2010 : 667–685. [CrossRef] [Google Scholar]
Rainer Q, Gardier AM, Hen R, David DJ. Mécanismes des effets comportementaux de type anxiolytique/antidépresseur de la fluoxétine (Prozac^®): implication de la neurogenèse hippocampique. Med Sci (Paris) 2009 ; 25 : 795–798. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987 ; 7 : 329–332. [CrossRef] [PubMed] [Google Scholar]
Burghardt NS, Bush DE, McEwen BS, LeDoux JE. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 2007 ; 62 : 1111–1118. [CrossRef] [PubMed] [Google Scholar]
Bockaert J, Claeysen S, Dumuis A, Marin P, Müller CP, Jacobs BL. Classification and signaling characteristics of 5-HT receptors. Handbook of the behavioral neurobiology of serotonin. London : Academic Press, 2010 : 103–121. [CrossRef] [Google Scholar]
Videtic A, Peternelj TT, Zupanc T, et al. Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009 ; 8 : 541–545. [CrossRef] [PubMed] [Google Scholar]
Labasque M, Meffre J, Carrat G, et al. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Mol Pharmacol 2010 ; 78 : 818–826. [CrossRef] [PubMed] [Google Scholar]
Heisler LK, Zhou L, Bajwa P, et al. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 2007 ; 6 : 491–496. [CrossRef] [PubMed] [Google Scholar]
Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry 2016 ; 21 : 450–463. [CrossRef] [PubMed] [Google Scholar]
Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature 2013 ; 496 : 224–228. [CrossRef] [PubMed] [Google Scholar]
Marcinkiewcz CA, Mazzone CM, D’Agostino G, et al. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature 2016 ; 537 : 97–101. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Guimarães FS, Zangrossi H, Jr, Del Ben CM, Graeff FG, Müller CP, Jacobs BL. Serotonin in panic and anxiety disorders. Handbook of the behavioral neurobiology of serotonin. London : Academic Press, 2010 : 667–685. [CrossRef] [Google Scholar]

[2] Rainer Q, Gardier AM, Hen R, David DJ. Mécanismes des effets comportementaux de type anxiolytique/antidépresseur de la fluoxétine (Prozac^®): implication de la neurogenèse hippocampique. Med Sci (Paris) 2009 ; 25 : 795–798. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

[3] Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987 ; 7 : 329–332. [CrossRef] [PubMed] [Google Scholar]

[4] Burghardt NS, Bush DE, McEwen BS, LeDoux JE. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 2007 ; 62 : 1111–1118. [CrossRef] [PubMed] [Google Scholar]

[5] Bockaert J, Claeysen S, Dumuis A, Marin P, Müller CP, Jacobs BL. Classification and signaling characteristics of 5-HT receptors. Handbook of the behavioral neurobiology of serotonin. London : Academic Press, 2010 : 103–121. [CrossRef] [Google Scholar]

[6] Videtic A, Peternelj TT, Zupanc T, et al. Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009 ; 8 : 541–545. [CrossRef] [PubMed] [Google Scholar]

[7] Labasque M, Meffre J, Carrat G, et al. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Mol Pharmacol 2010 ; 78 : 818–826. [CrossRef] [PubMed] [Google Scholar]

[8] Heisler LK, Zhou L, Bajwa P, et al. Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 2007 ; 6 : 491–496. [CrossRef] [PubMed] [Google Scholar]

[9] Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry 2016 ; 21 : 450–463. [CrossRef] [PubMed] [Google Scholar]

[10] Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature 2013 ; 496 : 224–228. [CrossRef] [PubMed] [Google Scholar]

[11] Marcinkiewcz CA, Mazzone CM, D’Agostino G, et al. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature 2016 ; 537 : 97–101. [CrossRef] [PubMed] [Google Scholar]